KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Change in Cash (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed Change in Cash for 9 consecutive years, with $40.0 million as the latest value for Q4 2025.

  • Quarterly Change in Cash rose 281.82% to $40.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $77.0 million through Dec 2025, down 33.62% year-over-year, with the annual reading at $77.0 million for FY2025, 33.62% down from the prior year.
  • Change in Cash hit $40.0 million in Q4 2025 for Elanco Animal Health, up from -$34.0 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $185.0 million in Q4 2021 to a low of -$296.0 million in Q1 2022.
  • Historically, Change in Cash has averaged $2.0 million across 5 years, with a median of $5.5 million in 2021.
  • Biggest five-year swings in Change in Cash: plummeted 3388.89% in 2022 and later surged 3600.0% in 2024.
  • Year by year, Change in Cash stood at $185.0 million in 2021, then crashed by 162.16% to -$115.0 million in 2022, then surged by 85.22% to -$17.0 million in 2023, then dropped by 29.41% to -$22.0 million in 2024, then surged by 281.82% to $40.0 million in 2025.
  • Business Quant data shows Change in Cash for ELAN at $40.0 million in Q4 2025, -$34.0 million in Q3 2025, and $52.0 million in Q2 2025.